157 related articles for article (PubMed ID: 1001205)
21. [Therapy of hyperlipemia and hyperuricemia with a combination of clofibrate and an extractive mucopolysaccharide complex].
Loizzi P; Terlizzi N
Reumatismo; 1975; 27(1):157-62. PubMed ID: 184507
[No Abstract] [Full Text] [Related]
22. [The effect of etofibrate on serum cholesterol and triglycerides (author's transl)].
Dimroth H
Med Klin; 1979 Jun; 74(22):875-6. PubMed ID: 470785
[TBL] [Abstract][Full Text] [Related]
23. Effect of calcium p-chlorphenoxyisobutyrate and calcium carbonate on plasma lipids and lipoproteins of patients with hyperlipoproteinaemia.
Koskinen P; Inkovaara J; Ala-Kaila K; Salo M; Nikkari T
Ann Clin Res; 1977 Dec; 9(6):335-41. PubMed ID: 356720
[TBL] [Abstract][Full Text] [Related]
24. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
Orö L; Olsson AG; Rössner S; Carlson LA
Postgrad Med J; 1975; 51(8):suppl 76-81. PubMed ID: 215986
[TBL] [Abstract][Full Text] [Related]
25. [Long-term effect of alufibrate in various types of hyperlipidaemia (author's transl)].
Stähelin HB; Hartmann G
Dtsch Med Wochenschr; 1974 Jun; 99(26):1392-4 passim. PubMed ID: 4601124
[No Abstract] [Full Text] [Related]
26. The effect of combined treatment with phenformin and stanazolol on blood lipids and fibrinolytic activity in patients with hypertriglyceridaemia.
Ciświcka-Sznajderman M; Berent H; Rymaszewski Z
Atherosclerosis; 1974; 19(1):153-9. PubMed ID: 4359182
[No Abstract] [Full Text] [Related]
27. [Clinical picture and treatment of insulin resistance in primary hyperlipoproteinaemia (author's transl)].
Vogelberg KH; Gries FA; Dietel J
Dtsch Med Wochenschr; 1973 Sep; 98(38):1751-8. PubMed ID: 4355086
[No Abstract] [Full Text] [Related]
28. [The when and how of therapy for hyperlipoproteinemia].
Mordasini R
Schweiz Med Wochenschr; 1978 Jan; 108(4):113-9. PubMed ID: 203028
[TBL] [Abstract][Full Text] [Related]
29. [Current trends in the therapy of arteriosclerotic disease].
Toscano S
G Clin Med; 1974 Jan; 55(1):27-39. PubMed ID: 4369524
[No Abstract] [Full Text] [Related]
30. Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.
Grundy SM; Mok HY
J Lab Clin Med; 1977 Feb; 89(2):354-66. PubMed ID: 833472
[TBL] [Abstract][Full Text] [Related]
31. [Clofibrate in type IIa hyperlipoproteinemia. Reduction of apolipoprotein B (author's transl)].
Mertz DP; Suermann I; Göhmann E
MMW Munch Med Wochenschr; 1978 Aug; 120(34):1097-9. PubMed ID: 210375
[TBL] [Abstract][Full Text] [Related]
32. Hypolipidemic effect of tibric acid. A comparison with clofibrate and placebo in type IV hyperlipoproteinemia.
Bielmann P; Brun D; Moorjani S; Gagnon MA; Tétreault L; Lupien PJ
Int J Clin Pharmacol Biopharm; 1977 Apr; 15(4):166-71. PubMed ID: 192685
[TBL] [Abstract][Full Text] [Related]
33. [Comparative studies on the cholesterol and triglyceride-lowering effect of alpha-methylthyroxine (Skleronorm) and clofibrate (Regelan) in hyperlipoproteinemias of type IIa/b and IV].
Jantke J; Schwartzkopff W; Zschiedrich M
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():392-5. PubMed ID: 206057
[No Abstract] [Full Text] [Related]
34. Differential drug therapy of the hyperlipoproteinaemias. The efficacy of lipid lowering drugs alone and in combination.
Hansen PF
Postgrad Med J; 1975; 51(8):suppl 63-5. PubMed ID: 1052927
[TBL] [Abstract][Full Text] [Related]
35. Effect of ursodeoxycholic acid on bile supersaturated with cholesterol in patients pretreated with clofibrate.
Kutz K; Schulte A
Z Gastroenterol; 1981 May; 19(5):231-6. PubMed ID: 7257479
[TBL] [Abstract][Full Text] [Related]
36. [Combination or monotherapy of hyperlipoproteinemia typus IIb, IV, V with clofibrate and m-inositolnicotinate or clofibrinic acid (author's transl)].
Schwartzkopff W; Zschiedrich M
Med Klin; 1978 Feb; 73(7):231-9. PubMed ID: 203832
[TBL] [Abstract][Full Text] [Related]
37. [New drug combination for medical management of hyperlipemia: clinical study].
Fischer M; Falkensammer C
Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):585-9. PubMed ID: 340391
[TBL] [Abstract][Full Text] [Related]
38. [Influence of etofibrate on plasmaviscosity in hyperlipoproteinemias (author's transl)].
Pfeiffer M; Tilsner V
Med Klin; 1978 Jan; 73(2):60-2. PubMed ID: 622057
[No Abstract] [Full Text] [Related]
39. [Clinical and therapeutic evaluation of a new antilipemic substance].
de Aguiar Magano L
Arch Sci Med (Torino); 1980; 137(1):131-9. PubMed ID: 7458646
[TBL] [Abstract][Full Text] [Related]
40. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
Gustafson A
Postgrad Med J; 1975; 51(8):suppl 66-71. PubMed ID: 215983
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
